EFFECTIVENESS OF GANGLION IMPAR BLOCK VERSUS CAUDAL EPIDURAL STEROID INJECTION IN THE PAIN MANAGEMENT OF COCCYGODYNIA: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.71000/h26k8a07Keywords:
Coccydynia, Caudal Epidural Steroid Injection, Ganglion Impar Block, Numeric Rating Scale, Oswestry Disability Index, Pain Management, Visual Analog ScaleAbstract
Background: Coccydynia is a chronic pain condition affecting the coccyx, often resulting in significant discomfort and reduced quality of life. It disproportionately affects women, especially following childbirth. While conservative management is effective in most cases, a subset of patients remains refractory and requires interventional treatments. Ganglion Impar Block (GIB) and Caudal Epidural Steroid Injection (CESI) are two widely used procedures, each with distinct mechanisms. However, a clear comparative evaluation is lacking, particularly regarding their integration with physical rehabilitation strategies.
Objective: To systematically evaluate and compare the clinical effectiveness and safety of GIB and CESI in the treatment of chronic coccydynia, with particular attention to pain relief, functional improvement, and quality of life outcomes.
Methods: This systematic review adhered to PRISMA guidelines and included studies published between January 2015 and March 2025 from PubMed, Cochrane Library, and Google Scholar. Nineteen studies—including 6 randomized controlled trials, 8 retrospective studies, and 1 narrative review—were selected based on predefined eligibility criteria. Included studies reported on adults with chronic coccydynia treated with either GIB or CESI. Data on pain (VAS/NRS), function (ODI), and quality of life (SF-12) were extracted and qualitatively synthesized due to methodological heterogeneity.
Results: GIB demonstrated superior short-term pain relief, with an average VAS reduction of 5.2 ± 1.3 compared to 3.8 ± 1.1 for CESI (p<0.05). In neuropathic presentations (LANSS ≥12), GIB was significantly more effective. Both interventions improved functional outcomes and SF-12 scores by week 3, although benefits diminished by 3 months. Adverse events were minor, including transient syncope and superficial bruising. There was limited evidence supporting the efficacy of combined GIB and CESI or their use alongside physiotherapy.
Conclusion: GIB is more effective for short-term pain control in chronic coccydynia, particularly in neuropathic cases, while CESI remains valuable in inflammatory profiles. Both are safe and improve patient function. Future randomized trials should assess multimodal strategies, including physiotherapy, to optimize treatment algorithms.
References
Kowalewski K, Egen L, Fischetti C, Puliatti S, Juan GR, Taratkin M, et al. Artificial intelligence for renal cancer: From imaging to histology and beyond. Asian Journal of Urology. 2022;9:243-52.
Xiong Y, Yao L, Lin J, Yao J, Bai Q, Huang Y, et al. Artificial intelligence links CT images to pathologic features and survival outcomes of renal masses. Nat Commun. 2025;16(1):1425.
Zhu X, Qin R, Qu K, Wang Z, Zhao X, Xu W. Atomic force microscopy-based assessment of multimechanical cellular properties for classification of graded bladder cancer cells and cancer early diagnosis using machine learning analysis. Acta Biomater. 2023;158:358-73.
Jhumka K, Khan MH-M, Mungloo-Dilmohamud Z, Fedally S. Classification of kidney abnormalities using deep learning with explainable AI. 2023 Sixth International Conference of Women in Data Science at Prince Sultan University (WiDS PSU). 2023:133-7.
Chen S, Jiang L, Zheng X, Shao J, Wang T, Zhang E, et al. Clinical use of machine learning-based pathomics signature for diagnosis and survival prediction of bladder cancer. Cancer Sci. 2021;112(7):2905-14.
Wei Z, Xv Y, Liu H, Li Y, Yin S, Xie Y, et al. A CT-based deep learning model predicts overall survival in patients with muscle invasive bladder cancer after radical cystectomy: a multicenter retrospective cohort study. Int J Surg. 2024;110(5):2922-32.
Lu MY, Williamson DFK, Chen TY, Chen RJ, Barbieri M, Mahmood F. Data-efficient and weakly supervised computational pathology on whole-slide images. Nat Biomed Eng. 2021;5(6):555-70.
Dai C, Xiong Y, Zhu P, Yao L, Lin J, Yao J, et al. Deep Learning Assessment of Small Renal Masses at Contrast-enhanced Multiphase CT. Radiology. 2024;311(2):e232178.
Koo KC, Yoo JW, Lee KS, Chung BH. Deep learning diagnostics for bladder tumor identification and grade prediction using RGB method. European Urology. 2023.
Chen S, Wang X, Zhang J, Jiang L, Gao F, Xiang J, et al. Deep learning-based diagnosis and survival prediction of patients with renal cell carcinoma from primary whole slide images. Pathology. 2024;56(7):951-60.
Chen S, Gao F, Guo T, Jiang L, Zhang N, Wang X, et al. Deep learning-based multi-model prediction for disease-free survival status of patients with clear cell renal cell carcinoma after surgery: a multicenter cohort study. Int J Surg. 2024;110(5):2970-7.
Lenis AT, Litwin MS. Does Artificial Intelligence Meaningfully Enhance Cystoscopy? J Natl Cancer Inst. 2022;114(2):174-5.
Feretzakis G, Juliebø-Jones P, Tsaturyan A, Şener T, Verykios V, Karapiperis D, et al. Emerging Trends in AI and Radiomics for Bladder, Kidney, and Prostate Cancer: A Critical Review. Cancers. 2024;16.
Saliby RM, Labaki C, Jammihal TR, Xie W, Sun M, Shah V, et al. Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes. Cancer Cell. 2024;42(5):732-5.
Li S, Zhou Z, Gao M, Liao Z, He K, Qu W, et al. Incremental value of automatically segmented perirenal adipose tissue for pathological grading of clear cell renal cell carcinoma: a multicenter cohort study. Int J Surg. 2024;110(7):4221-30.
Cheng G, Zhou Z, Li S, Ye Z, Wang Y, Wen J, et al. Integration of proteomics and transcriptomics to construct a prognostic signature of renal clear cell carcinoma. Int J Med Sci. 2024;21(11):2215-32.
Song DM, Shen T, Feng K, He YB, Chen SL, Zhang Y, et al. LIG1 is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing. Front Immunol. 2024;15:1419126.
Wang Z, Chen DN, Huang XY, Zhu JM, Lin F, You Q, et al. Machine learning-based autophagy-related prognostic signature for personalized risk stratification and therapeutic approaches in bladder cancer. Int Immunopharmacol. 2024;138:112623.
Xiong S, Fu Z, Deng Z, Li S, Zhan X, Zheng F, et al. Machine learning-based CT radiomics enhances bladder cancer staging predictions: A comparative study of clinical, radiomics, and combined models. Med Phys. 2024;51(9):5965-77.
Meng XY, Zhou XH, Li S, Shi MJ, Li XH, Yang BY, et al. Machine Learning-Based Detection of Bladder Cancer by Urine cfDNA Fragmentation Hotspots that Capture Cancer-Associated Molecular Features. Clin Chem. 2024;70(12):1463-73.
Motzer RJ, Banchereau R, Hamidi H, Powles T, McDermott D, Atkins MB, et al. Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade. Cancer Cell. 2020;38(6):803-17.e4.
Huang KB, Gui CP, Xu YZ, Li XS, Zhao HW, Cao JZ, et al. A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma. Nat Commun. 2024;15(1):6215.
Roussel E, Capitanio U, Kutikov A, Oosterwijk E, Pedrosa I, Rowe SP, et al. Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review. Eur Urol. 2022;81(5):476-88.
Li H, Wang F, Huang W. A Novel, Simple, and Low-Cost Approach for Machine Learning Screening of Kidney Cancer: An Eight-Indicator Blood Test Panel with Predictive Value for Early Diagnosis. Curr Oncol. 2022;29(12):9135-49.
Zheng Z, Dai F, Liu J, Zhang Y, Wang Z, Wang B, et al. Pathology-based deep learning features for predicting basal and luminal subtypes in bladder cancer. BMC Cancer. 2025;25(1):310.
Timofeeva E, Azilgareeva С, Morozov A, Taratkin M, Enikeev D. Use of artificial intelligence in the diagnosis, treatment and surveillance of patients with kidney cancer. Urology Herald. 2023.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Kinza Arif , Ayesha Mohsin, Waqas Ashraf, Muhammad Junaid Akram, Hammad Nisar, M. Abdullah Hamza Masood, Zeeshan Habib (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
